These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 7541801

  • 1. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
    De Bellis A, Bizzarro A, Gattoni A, Romano C, Di Martino S, Sinisi AA, Abbadessa S, Bellastella A.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
    [Abstract] [Full Text] [Related]

  • 2. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
    Modelska-Ziółkiewicz A, Gembicki M, Sowiński J.
    Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
    [Abstract] [Full Text] [Related]

  • 3. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy.
    De Bellis A, Di Martino S, Fiordelisi F, Muccitelli VI, Sinisi AA, Abbate GF, Gargano D, Bellastella A, Bizzarro A.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1222-5. PubMed ID: 9543145
    [Abstract] [Full Text] [Related]

  • 4. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy.
    Wakelkamp IM, Gerding MN, van der Meer JW, Prummel MF, Wiersinga WM.
    Clin Exp Immunol; 2002 Feb; 127(2):316-20. PubMed ID: 11876756
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic role of adhesion molecules sELAM-1 and sICAM-1 in glucocorticoid therapy of active ophthalmopathy].
    Modelska-Ziółkiewicz A, Gembicki M, Bednarek J, Sowiński J.
    Pol Arch Med Wewn; 2003 May; 109(5):469-75. PubMed ID: 14768175
    [Abstract] [Full Text] [Related]

  • 6. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
    De Bellis A, Sansone D, Coronella C, Conte M, Iorio S, Perrino S, Battaglia M, Bellastella G, Wall JR, Bellastella A, Bizzarro A.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
    [Abstract] [Full Text] [Related]

  • 7. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism.
    Wenisch C, Myskiw D, Gessl A, Graninger W.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2122-6. PubMed ID: 7541802
    [Abstract] [Full Text] [Related]

  • 8. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves' disease with or without ophthalmopathy.
    Ozata M, Bolu E, Sengül A, Altinsoy HI, Turan M, Corakci A, Hacibektasoglu A, Gundogan MA.
    Endocr J; 1996 Oct; 43(5):517-25. PubMed ID: 8980891
    [Abstract] [Full Text] [Related]

  • 9. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves' ophthalmopathy and thyroid diseases.
    Heufelder AE, Bahn RS.
    Clin Exp Immunol; 1993 May; 92(2):296-302. PubMed ID: 8097976
    [Abstract] [Full Text] [Related]

  • 10. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C, Kiss E.
    Acta Microbiol Immunol Hung; 1994 May; 41(4):451-6. PubMed ID: 7866729
    [Abstract] [Full Text] [Related]

  • 11. Soluble endothelium-associated adhesion molecules in patients with Graves' disease.
    Wenisch C, Myskiw D, Parschalk B, Hartmann T, Dam K, Graninger W.
    Clin Exp Immunol; 1994 Nov; 98(2):240-4. PubMed ID: 7525128
    [Abstract] [Full Text] [Related]

  • 12. [Assessment of soluble E selectin levels in patients with Graves' disease and thyroid orbitopathy].
    Kulig G, Pilarska K, Kulig J, Robaczyk M, Gromniak E.
    Przegl Lek; 2004 Nov; 61(12):1314-8. PubMed ID: 15850320
    [Abstract] [Full Text] [Related]

  • 13. [Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves' ophthalmopathy].
    Kulig G, Pilarska K, Kulig J, Krzyzanowska-Swiniarska B, Robaczyk M, Baraniak A.
    Pol Arch Med Wewn; 2002 Dec; 108(6):1161-9. PubMed ID: 12687928
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment.
    Kowalzick L, Kleinheinz A, Neuber K, Weichenthal M, Köhler I, Ring J.
    Dermatology; 1995 Dec; 190(1):14-8. PubMed ID: 7534511
    [Abstract] [Full Text] [Related]

  • 15. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves' disease: correlation with disease activity and treatment status.
    Fukazawa H, Yoshida K, Kaise N, Kiso Y, Sayama N, Mori K, Kikuchi K, Aizawa Y, Rikimaru A, Abe K.
    Thyroid; 1995 Oct; 5(5):373-7. PubMed ID: 8563475
    [Abstract] [Full Text] [Related]

  • 16. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity.
    Jakobsen PH, Morris-Jones S, Rønn A, Hviid L, Theander TG, Elhassan IM, Bygbjerg IC, Greenwood BM.
    Immunology; 1994 Dec; 83(4):665-9. PubMed ID: 7533138
    [Abstract] [Full Text] [Related]

  • 17. [The role od adhesion molecules in the pathogenesis of Graves ophthalmopathy].
    Kulig G, Pilarska K.
    Klin Oczna; 2001 Dec; 103(2-3):147-50. PubMed ID: 11873415
    [Abstract] [Full Text] [Related]

  • 18. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I, Estrach MT.
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [Abstract] [Full Text] [Related]

  • 19. [Serum levels of adhesion molecules (sICAM-1, sVCAM-1 and sP-selectin) in children and adolescents with thyroid diseases].
    Bossowski A, Urban M, Citko A, Sobotko J, Bossowska A.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2000 Aug; 6(2):79-92. PubMed ID: 12818068
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease.
    Sonnet E, Massart C, Gibassier J, Allannic H, Maugendre D.
    J Endocrinol Invest; 1999 Jun; 22(6):430-5. PubMed ID: 10435852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.